GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » YoY EBITDA Growth

MustGrow Biologics (TSXV:MGRO) YoY EBITDA Growth : -10.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MustGrow Biologics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -10.00%.

MustGrow Biologics's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.02.


MustGrow Biologics YoY EBITDA Growth Historical Data

The historical data trend for MustGrow Biologics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics YoY EBITDA Growth Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial 21.62 -50.00 20.69 -63.77 87.61

MustGrow Biologics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.04 -4.76 -27.59 258.14 -10.00

MustGrow Biologics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

MustGrow Biologics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.014--0.113)/ | -0.113 |
=87.61 %

MustGrow Biologics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.022--0.02)/ | -0.02 |
=-10.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MustGrow Biologics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


MustGrow Biologics (TSXV:MGRO) Business Description

Traded in Other Exchanges
Address
1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.
Executives
Corey Joseph Giasson Director, Senior Officer
Colin Michael Bletsky Director

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines